Literature DB >> 23357644

Genetic characterization of human respiratory syncytial virus detected in hospitalized children in the Philippines from 2008 to 2012.

Ayumu Ohno1, Akira Suzuki, Socorro Lupisan, Hazel Galang, Lydia Sombrero, Rapunzel Aniceto, Michiko Okamoto, Mariko Saito, Naoko Fuji, Hirono Otomaru, Chandra Nath Roy, Dai Yamamoto, Raita Tamaki, Remigio Olveda, Hitoshi Oshitani.   

Abstract

BACKGROUND: Human respiratory syncytial virus (HRSV) is the leading cause of acute lower respiratory tract infection in infants and young children. However, molecular characteristic of HRSV is still unknown in the Philippines.
OBJECTIVE: To describe the molecular epidemiology of circulating HRSV detected in the Philippines. STUDY
DESIGN: From May 2008 to April 2012, nasopharyngeal swabs were collected from infants and children aged between 7 days and 14 years who were hospitalized with severe pneumonia. HRSV was detected by nested PCR targeting M2 gene, and C-terminus of the G gene was sequenced for phylogenetic analysis. RESULT: Out of total 2150 samples, 19.3% (n = 415) were positive for HRSV, and 65.0% of them (n = 270) were identified as HRSV-A and 35.0% (n = 145) as HRSV-B. There were two major HRSV outbreaks: between June 2008 and February 2009, and between June and March 2012. Majority of HRSV strains detected during the former outbreak were HRSV-A (97.5%, 203/208) whereas during the later outbreak, both HRSV-A (54/158, 34.2%) and HRSV-B (104/158, 65.8%) were detected. All HRSV-A strains were classified as genotype NA1 and all HRSV-B as genotype BA, which had 60-nucleotide duplication in secondary hypervariable region of the G gene. Among HRSV-B positive samples, there were 2 distinct clusters with unique amino acid changes and low homology in compared to other strains in BA, suggesting emergence of new variant of HRSV-B.
CONCLUSION: The study provides an overview of the genetic variation in circulating HRSV viruses in the Philippines along with identification of possibly a novel variant of HRSV-B.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23357644     DOI: 10.1016/j.jcv.2013.01.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  17 in total

1.  Prevalence and genetic characterisation of respiratory syncytial viruses circulating in Bulgaria during the 2014/15 and 2015/16 winter seasons.

Authors:  Neli Korsun; Svetla Angelova; Iren Tzotcheva; Irina Georgieva; Snezhina Lazova; Snezhana Parina; Ivaylo Alexiev; Penka Perenovska
Journal:  Pathog Glob Health       Date:  2017-09-26       Impact factor: 2.894

2.  Molecular evolution of enterovirus 68 detected in the Philippines.

Authors:  Tadatsugu Imamura; Akira Suzuki; Socorro Lupisan; Michiko Okamoto; Rapunzel Aniceto; Rutchie J Egos; Edgardo E Daya; Raita Tamaki; Mariko Saito; Naoko Fuji; Chandra Nath Roy; Jaime M Opinion; Arlene V Santo; Noel G Macalalad; Amado Tandoc; Lydia Sombrero; Remigio Olveda; Hitoshi Oshitani
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

3.  Differences in viral load among human respiratory syncytial virus genotypes in hospitalized children with severe acute respiratory infections in the Philippines.

Authors:  Francois Marie Ngako Kadji; Michiko Okamoto; Yuki Furuse; Raita Tamaki; Akira Suzuki; Irene Lirio; Clyde Dapat; Rungnapa Malasao; Mariko Saito; Gay Anne Granada Pedrera-Rico; Veronica Tallo; Socorro Lupisan; Mayuko Saito; Hitoshi Oshitani
Journal:  Virol J       Date:  2016-06-27       Impact factor: 4.099

4.  Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014.

Authors:  Anwar Ahmed; Shakir H Haider; Shama Parveen; Mohammed Arshad; Hytham A Alsenaidy; Alawi Omar Baaboud; Khalid Fahad Mobaireek; Muslim Mohammed AlSaadi; Abdulrahman M Alsenaidy; Wayne Sullender
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

5.  Genetic diversity of human respiratory syncytial virus circulating among children in Ibadan, Nigeria.

Authors:  Olukunle Ogunsemowo; David O Olaleye; Georgina N Odaibo
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

6.  Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012-2015.

Authors:  Ilada Thongpan; John Mauleekoonphairoj; Preeyaporn Vichiwattana; Sumeth Korkong; Rujipat Wasitthankasem; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PeerJ       Date:  2017-10-27       Impact factor: 2.984

7.  Molecular Characterization of Human Respiratory Syncytial Virus in the Philippines, 2012-2013.

Authors:  Rungnapa Malasao; Michiko Okamoto; Natthawan Chaimongkol; Tadatsugu Imamura; Kentaro Tohma; Isolde Dapat; Clyde Dapat; Akira Suzuki; Mayuko Saito; Mariko Saito; Raita Tamaki; Gay Anne Granada Pedrera-Rico; Rapunzel Aniceto; Reynaldo Frederick Negosa Quicho; Edelwisa Segubre-Mercado; Socorro Lupisan; Hitoshi Oshitani
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

8.  Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups a and B in children in recent five consecutive years.

Authors:  Guanglin Cui; Runan Zhu; Yuan Qian; Jie Deng; Linqing Zhao; Yu Sun; Fang Wang
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

9.  Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014.

Authors:  Jinhua Song; Huiling Wang; Jing Shi; Aili Cui; Yanzhi Huang; Liwei Sun; Xingyu Xiang; Chaofeng Ma; Pengbo Yu; Zifeng Yang; Qi Li; Teresa I Ng; Yan Zhang; Rongbo Zhang; Wenbo Xu
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

10.  Molecular epidemiology of human respiratory syncytial virus among children in Japan during three seasons and hospitalization risk of genotype ON1.

Authors:  Akinobu Hibino; Reiko Saito; Kiyosu Taniguchi; Hassan Zaraket; Yugo Shobugawa; Tamano Matsui; Hiroshi Suzuki
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.